Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Huang, Huaqiong
NCT05243680 / 2020-004334-38: An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103)	Active, not recruiting	3	641	Europe, Canada, Japan, US, RoW	GSK3511294 (Depemokimab)	GlaxoSmithKline, Iqvia Pty Ltd	Asthma	05/25	05/25
NCT04932551: Perspectives and Management of Atypical Asthma	Recruiting	N/A	5000	RoW	Questionnaire	Second Affiliated Hospital, School of Medicine, Zhejiang University	Asthma	06/21	12/21